• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米结构脂质载体作为一种新型的芒果苷眼部给药系统:提高体内眼生物利用度。

Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.

机构信息

College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, People's Republic of China.

出版信息

J Pharm Sci. 2012 Oct;101(10):3833-44. doi: 10.1002/jps.23251. Epub 2012 Jul 5.

DOI:10.1002/jps.23251
PMID:22767401
Abstract

The aim of this study was to develop a novel nanostructured lipid carriers (NLCs) system to improve ocular bioavailability of mangiferin (MGN) for the potential treatment of cataract. The physicochemical properties of MGN-loaded NLC (MGN-NLC) formulation were characterized by particle size, polydispersity index, zeta potential, entrapment efficiency, drug loading, morphological property, and crystalline state. in vitro characteristics were investigated by drug release from NLC system, physical stability, and corneal permeation through excised rabbit cornea. Moreover, in vivo ocular tolerability was assessed by a modified Draize test and histological microscopy. Preocular retention capability was evaluated by slit-lamp observation. Pharmacokinetic study in the aqueous humor was performed by microdialysis technique. Transmission electron microscopy depicted spherical and uniform morphology. Differential scanning calorimetry and X-ray diffractometry displayed imperfect crystalline lattice. The optimized MGN-NLC formulation exhibited a sustained drug release with 3 months stability and 4.31-fold increase of in vitro corneal permeation. Furthermore, in vivo studies exhibited a high tolerance in the ocular tissues and prolonged drug retention capacity on the corneal surface. Finally, pharmacokinetic study suggested a 5.69-fold increase of ocular bioavailability compared with MGN solution (MGN-SOL). Therefore, NLC system is a promising approach for ocular delivery of MGN.

摘要

本研究旨在开发一种新型的纳米结构脂质载体(NLC)系统,以提高芒果苷(MGN)的眼部生物利用度,用于白内障的潜在治疗。通过粒径、多分散指数、Zeta 电位、包封效率、载药量、形态特性和晶体状态对载药 NLC(MGN-NLC)制剂的理化性质进行了表征。通过 NLC 系统的药物释放、物理稳定性和通过离体兔角膜的角膜渗透来研究体外特性。此外,通过改良的 Draize 试验和组织学显微镜评估体内眼耐受性。通过裂隙灯观察评估预眼滞留能力。通过微透析技术进行房水药代动力学研究。透射电子显微镜显示出球形和均匀的形态。差示扫描量热法和 X 射线衍射法显示出不完美的晶体晶格。优化的 MGN-NLC 制剂表现出持续的药物释放,具有 3 个月的稳定性和体外角膜渗透增加 4.31 倍。此外,体内研究表明,眼部组织具有高耐受性,并且在角膜表面具有延长的药物滞留能力。最后,药代动力学研究表明,与 MGN 溶液(MGN-SOL)相比,眼部生物利用度提高了 5.69 倍。因此,NLC 系统是一种有前途的 MGN 眼部递药方法。

相似文献

1
Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.纳米结构脂质载体作为一种新型的芒果苷眼部给药系统:提高体内眼生物利用度。
J Pharm Sci. 2012 Oct;101(10):3833-44. doi: 10.1002/jps.23251. Epub 2012 Jul 5.
2
Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.壳聚糖-N-乙酰半胱氨酸、壳寡糖或羧甲基壳聚糖修饰的香豆素-6 载药纳米脂质载体经兔眼的转运机制。
Eur J Pharm Biopharm. 2017 Nov;120:89-97. doi: 10.1016/j.ejpb.2017.08.013. Epub 2017 Sep 1.
3
Design of Nanotechnological Carriers for Ocular Delivery of Mangiferin: Preformulation Study.芒果苷眼用纳米载药系统的设计:制剂前研究。
Molecules. 2022 Feb 16;27(4):1328. doi: 10.3390/molecules27041328.
4
Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone.基于纳米结构脂质载体的热敏性眼用制剂,用于增强和持续递送达塞米松。
Nanomedicine (Lond). 2018 Jun;13(11):1239-1253. doi: 10.2217/nnm-2017-0318.
5
Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.基于纳米结构脂质载体(NLC)的丙酸氯倍他索控释局部用凝胶:设计与体内表征
Drug Deliv Transl Res. 2016 Jun;6(3):289-98. doi: 10.1007/s13346-016-0291-1.
6
Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery.具有部分脱乙酰水溶性壳聚糖的新型表面修饰的纳米结构脂质载体,用于高效眼部递药。
J Pharm Sci. 2012 Mar;101(3):1040-9. doi: 10.1002/jps.22813. Epub 2011 Nov 18.
7
Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.开发一种新的传递系统,由“药物-环糊精-纳米结构脂质载体”组成,用于酮洛芬的局部传递。
Eur J Pharm Biopharm. 2012 Jan;80(1):46-53. doi: 10.1016/j.ejpb.2011.07.015. Epub 2011 Aug 4.
8
Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.载有氯替泼诺酯的阳离子纳米乳化原位眼用凝胶的研制,用于持续给药并提高眼部生物利用度。
Drug Deliv. 2016 Nov;23(9):3712-3723. doi: 10.1080/10717544.2016.1223225. Epub 2016 Sep 30.
9
Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies.热敏原位纳米凝胶作为姜黄素的眼部给药系统:研制、表征、体外渗透及体内药代动力学研究
Pharm Dev Technol. 2016 Aug;21(5):576-82. doi: 10.3109/10837450.2015.1026607. Epub 2015 May 29.
10
A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.一种新型口服给药系统,由“药物-环糊精-纳米结构脂质载体”组成,用于递送水中溶解度差的药物:长春西汀。
Int J Pharm. 2014 Apr 25;465(1-2):90-6. doi: 10.1016/j.ijpharm.2014.02.013. Epub 2014 Feb 12.

引用本文的文献

1
Polyphenolic protection: the role of mangiferin in mitigating neurodegeneration and neuroinflammation.多酚类物质的保护作用:芒果苷在减轻神经退行性变和神经炎症中的作用。
Inflammopharmacology. 2025 Jul 22. doi: 10.1007/s10787-025-01854-3.
2
Novel Carbon Dots Derived from Significantly Improve the Solubility and Bioavailability of Mangiferin.源自[具体物质]的新型碳点显著提高了芒果苷的溶解度和生物利用度。 (注:原文中“Significantly Improve the Solubility and Bioavailability of Mangiferin”前缺少具体物质,翻译时补充了[具体物质],以便句子意思完整)
Int J Nanomedicine. 2024 Apr 20;19:3611-3622. doi: 10.2147/IJN.S456053. eCollection 2024.
3
Activation of Heme Oxygenase-1 by Mangiferin in Human Retinal Pigment Epithelial Cells Contributes to Blocking Oxidative Damage.
芒果苷对人视网膜色素上皮细胞中血红素加氧酶-1的激活作用有助于阻止氧化损伤。
Biomol Ther (Seoul). 2024 May 1;32(3):329-340. doi: 10.4062/biomolther.2023.175. Epub 2024 Apr 9.
4
Therapeutic potential of mangiferin in cancer: Unveiling regulatory pathways, mechanisms of action, and bioavailability enhancements - An updated review.芒果苷在癌症治疗中的潜力:揭示调控途径、作用机制及生物利用度提高——最新综述
Food Sci Nutr. 2023 Dec 20;12(3):1413-1429. doi: 10.1002/fsn3.3869. eCollection 2024 Mar.
5
Chitosan as a promising materials for the construction of nanocarriers for diabetic retinopathy: an updated review.壳聚糖作为构建糖尿病视网膜病变纳米载体的一种有前景的材料:最新综述
J Biol Eng. 2024 Feb 22;18(1):18. doi: 10.1186/s13036-024-00414-7.
6
Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.纳米技术介导的草药纳米系统在眼科药物中的应用。
Pharm Nanotechnol. 2024;12(3):229-250. doi: 10.2174/2211738511666230816090046.
7
Preparation of a Sunitinib loaded microemulsion for ocular delivery and evaluation for the treatment of corneal neovascularization and .用于眼部给药的载有舒尼替尼的微乳剂的制备及其治疗角膜新生血管的评估
Front Pharmacol. 2023 Jul 11;14:1157084. doi: 10.3389/fphar.2023.1157084. eCollection 2023.
8
Nanocarriers for ocular drug delivery: Recent advances and future opportunities.用于眼部药物递送的纳米载体:最新进展与未来机遇。
Indian J Ophthalmol. 2023 Jun;71(6):2355-2366. doi: 10.4103/ijo.IJO_1893_22.
9
Nanoparticles for the treatment of glaucoma-associated neuroinflammation.用于治疗青光眼相关神经炎症的纳米颗粒。
Eye Vis (Lond). 2022 Jul 2;9(1):26. doi: 10.1186/s40662-022-00298-y.
10
Nanocarriers for ocular drug delivery: current status and translational opportunity.用于眼部药物递送的纳米载体:现状与转化机遇
RSC Adv. 2020 Jul 24;10(46):27835-27855. doi: 10.1039/d0ra04971a. eCollection 2020 Jul 21.